Integris Medtech plans Rs 3,000 crore IPO in late November
In short
Integris Medtech plans to launch its IPO in late November. The offer is expected to open on November 27 and close on December 1, and the company wants to raise ₹2,500 crore to ₹3,000 crore.
Most of the money will go toward reducing debt at its subsidiaries, with major investment banks handling the issue.
What the reporting says
Integris Medtech is set to launch its initial public offering in late November, with the issue expected to open on November 27 and close on December 1. The company aims to raise between ₹2,500 crore and ₹3,000 crore, and plans to use the proceeds mainly to reduce debt at its subsidiaries. Major investment banks are managing the public issue.
Why it matters
Integris Medtech is preparing a late-November IPO, with the offering expected to open on November 27 and close on December 1. The company aims to raise ₹2,500 crore to ₹3,000 crore, and the proceeds are planned mainly for debt reduction at its subsidiaries. The involvement of major investment banks indicates a large primary market transaction.